The human microbiome market comprises products that help maintain a healthy balance of microorganisms like bacteria, viruses, and fungi in the human body. Probiotics and prebiotics account for a significant share of the market. Probiotics are live microorganisms that, when taken in sufficient amounts, provide health benefits. Prebiotics are non-digestible fibers that act as food for probiotics and support their growth. The growing awareness about gut and overall health has increased the demand for probiotics and prebiotics in dietary supplements, foods, and beverages.
The Global Human Microbiome Market is estimated to be valued at US$ 4894.33 Mn in 2024 and is expected to exhibit a CAGR of 4.8% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the human microbiome market are Diageo plc, Pernod-Ricard SA, Constellation Brands Inc., Brown-Forman Corporation, Remy Cointreau SA, Marie Brizard Wine & Spirits, Lapostolle SA, and Berentzen-Gruppe AG. They are investing in R&D to develop innovative probiotic formulations and expand their product offerings.
The growing demand for digestive health and gut health products is a major factor driving the human microbiome market. Probiotics help maintain a balanced gut microbiota and support digestive functions. Their use has increased to manage conditions like Irritable Bowel Syndrome, constipation, diarrhea, and other gastrointestinal issues.
Technological advancements have enabled studying the Human Microbiome Market Growth composition better. Companies are developing precision probiotics tailored to individual microbiome profiles assessed through tests. This personalized approach is expected to boost the demand further over the forecast period.
Market Trends
Functional foods dominate product category- Major food companies are fortifying various food products like yogurt, juices, and snacks with probiotics and prebiotics making functional foods the largest revenue generating segment.
Precision and personalized probiotics gain traction-Testing kits that can profile an individual’s microbiome are enabling formulation of targeted probiotic supplements designed as per specific needs. This emerging trend will support market growth.
Market Opportunities
Gut-brain axis research progresses- Studies linking the gut microbiome to various neurological and psychological conditions like anxiety, depression, autism etc provide opportunities for probiotic interventions.
Health benefits beyond digestion explored- Researchers investigate novel mechanisms through which microbiome modulation may help manage non-communicable diseases like diabetes, cardiovascular conditions, and even cancer.
The COVID-19 pandemic has negatively impacted the growth of the human microbiome market. With lockdowns imposed worldwide, research activities were hampered as laboratories remained closed for most part of 2020 and 2021. This led to delay in new product development and launch of innovative solutions targeting human microbiota. Funding for microbiome-based therapy projects also reduced during the pandemic years.
However, with remote monitoring tools and work from home becoming new normals, companies pursued virtual clinical trials and research collaborations to sustain progress. Telehealth solutions gaining prominence helped players to continue engaging with healthcare providers and patients. Rising awareness about strengthening immunity led to increased demand for probiotic supplements and microbiome modulators. This provided opportunities to established brands to push their offerings online and through e-pharmacies or home delivery routes.
As the pandemic situation starts improving, corporate R&D investments as well as government funding are expected to rise significantly. Major biotech corporations and academic institutes have indicated plans to accelerate microbiome-focused drug development programs that were delayed. New tie-ups involving probiotic dietary formulations, toxicogenomics, and microbiome-based biosensors are likely to be announced. While virtual modes may continue supplementing on-ground research, reopening of clinical sites will help expedite trials and product approvals in the coming years.
In terms of geographical distribution, North America accounted for the largest value share in the human microbiome market prior to the pandemic, attributed to robust healthcare infrastructure and high adoption of advanced medical technologies in the US and Canada. Asia Pacific is projected as the fastest growing regional market owing to increasing expenditure on microbiome therapeutics by India and China coupled with supportive government policies promoting R&D activities in the biotech sector across Asian nations over the forecast period.
Get more insights on Human Microbiome Market
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
Comments
0 comment